Sera Prognostics Inc (SERA NASDAQ) stock market data APIs
$1.8107
0.12(6.6%)
as of May 6, 2026
Try our APIs with
free plan!
Sera Prognostics Inc Financial Data Overview
Price chart is built with
Anychart
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Prev. Close
1.8107
Open
1.9293
High
2.1036
Low
1.8031
52 wk Range
1.37-4.09
Market Cap
73 618 K
Shares Outstanding
38 191 K
Revenue
81 000
EPS
-0.16
Beta
0.925
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sera Prognostics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sera Prognostics Inc data using free add-ons & libraries
Get Sera Prognostics Inc Fundamental Data
Sera Prognostics Inc Fundamental data includes:
- Net Revenue: 81 000
- EBITDA: -35 680 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-25
- EPS/Forecast: -0.1854
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sera Prognostics Inc News
New
5 Top-Ranked Stocks With Rising P/E That Investors Can Bet On
Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio, the higher the stoc...
Sera Prognostics, Inc. Q4 2025 Earnings Call Summary
Sera Prognostics, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Transition from Clinical Validation to Market Adoption The company successfully transitioned from a research-heavy phase to comm...
Sera Prognostics outlines plan to expand partner programs to 15–17 states by year-end 2026 while maintaining cash runway through 2028
Earnings Call Insights: Sera Prognostics (SERA) Q4 2025 MANAGEMENT VIEW * President and CEO Evguenia Lindgardt highlighted 2025 as a pivotal year, emphasizing, "2025 was a critical year for Sera, ...
Sera Prognostics Q4 Earnings Call Highlights
Sera Prognostics logo Key Points PRIME was published in January 2026 and management highlighted it showed a 56% and 32% reduction in births before 32 and 35 weeks respectively, plus an asserted ~20%...
Get Sera Prognostics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
